Envisionit Deep AI

About

Envisionit Deep AI® (EDAI) is an innovative medical technology company with a holistic approach to Artificial Intelligence. Committed to the highest standards of ethical AI we aim to democratize access to diagnostic healthcare by enabling accurate, cost-effective, and timely diagnoses, regardless of geographic or economic barriers.

Our mission is to combine advanced Al algorithms with comprehensive validation and rigorous monitoring. We strive to ensure that our advancements prioritise patient well-being and equitable access, thereby exemplifying responsible innovation.

Guided by three founders, each with over twenty years of leadership and expertise in radiology, business and technology, the company stands as a leader in responsible AI innovation.

PROBLEM:
The need for accurate and timely diagnosis is paramount. Despite the expertise of healthcare professionals, the demand often exceeds capacity in the highly specialised field of radiology. In addition, AI tools in healthcare are confronted with a critical challenge: The absence of real-world prospective scientific evidence to substantiate their safety and efficacy.

SOLUTION:
We offer a comprehensive end-to-end solution with a holistic approach to AI. From initial training to development and seamless integration of AI, to ongoing post-market surveillance, monitoring, and feedback for quality assurance, research, and education. And because our solution stack incorporates all aspects applicable to our technology, this integrated approach creates a flywheel effect, fostering reinforcement, learning and adaptive AI capabilities.

Key Facts

FDA Approved | ISO 13485 | IEC 62304 | All AI tools with Post Market Surveillance & Real Time Feedback | AI Tools, Real Time AI Validation & Quality Assurance Monitoring | AI assisted Educational Tool

2021: CISCO GLOBAL PROBLEM SOLVER CHALLENGE

2022: BCX DIGITAL INNOVATION AWARDS

2022: GLOBAL STARTUP AWARDS – BEST NEWCOMER

2022: INNOVATE UK TRANSFORMATIVE TECHNOLOGY GRANT

 

Successes in UK/NHS

2020: Global Entrepreneur Programme (Department of Business and Trade) Appointed to the UK Government's Global Entrepreneur Programme. 2022/3: INNOVATE UK TRANSFORMATIVE TECHNOLOGY GRANT In 2022 that the company was awarded the Innovate UK's Transformative Technologies grant for RATify, their AI assurance tool, for its alignment with the National Institute for Health and Care Excellence guidelines for AI quality assurance. 2024: AI Summit (UK) Finalist - Solution Provider of the Year - AI Conics (winner to be announced 13 June 2024) 2024: Multiple pilots in the pipeline with various academic institutions

Company details

Solutions

Augmenting healthcare professionals

Improving quality & efficiency

Providing advanced screening and diagnostics

Specialism

Decision Support and treatment planning

Quality improvement

Specialised diagnostics

Company details

Want to connect with this innovator?

Make an enquiry

Revenue

£0-2m

Funding Status

Series A

Markets already exporting to

South Africa, Indonesia

Desired Markets

Africa, Europe, Middle East, North America, South-East Asia, South America, United Kingdom.

Desired customer types

Academic Hospitals, Private Hospitals, Medical Practices, Clinics, Mobile Clinics, Occupational Health Screening.

Want to connect with this innovator?
Make an enquiry
Close
This field is required
This field is required
This field is required
This field is required
This field is required

Thank you

We are processing your request and will return your contact as soon as possible.